Evaluation of Cytokines Level as an Indicator of Pulp Inflammation and Its Relation to the Success Rates of Pulpotomy in Primary Molars Affected With Proximal Versus Occlusal Decay

NCT ID: NCT07171229

Last Updated: 2025-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-01

Study Completion Date

2026-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

pulpotomy will be done I primary molars with occlusal or proximal decay and level of cytokines will be measured as an indicator for pulp inflammation levels

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The proposed trial interventions, pulpotomy, will follow standard clinical procedural guidelines. Participants will be allocated to one of the two intervention groups only after intra-operative confirmation of pulp vitality and achievement of radicular pulp hemostasis.

Standard clinical protocol for both groups with occlusal and proximal decay:

1. A detailed history of symptoms will be obtained, and a thorough clinical examination will be conducted.
2. Pre-operative pain intensity will be assessed using a validated five-face visual analog scale (VAS), where children select the face that best represents their pain level.
3. A standard pre-operative periapical radiograph will be taken, ensuring the image extends beyond the root tip and shows no distortion or processing errors.
4. Local anesthesia will be administered, and the tooth will be isolated with a rubber dam.
5. To minimize further bacterial contamination, carious tissues will be removed progressively, starting from the cavity periphery and then over the pulp chamber roof.
6. Before managing the pulpal hemorrhage, a sterile cotton pellet will be placed over the pulp tissue for 30-45 s. to obtain pulpal blood samples. The specimens will be collected into heparin-coated tubes with 1 mg saline solution and stored at - 20 °C (-4.0 °F) for 6 months until the day of testing.
7. A fresh sterile bur will be used to remove all coronal pulp tissue down to the root canal orifices, with copious water irrigation. Intra-operative assessment of pulp vitality will be conducted, with healthy vital pulp appearing as uniformly reddish-pink vascular tissue and non-vital pulp as dark avascular tissue or yellowish liquefied areas. If necrotic, the tooth will be excluded from the study, and local management protocols will be followed for treatment (Bas et al., 2024).
8. MTA will be used as medicament of choice for pulpotomy.
9. Once a 2-3 mm thickness is ensured, the cavity will be filled with restorative glass ionomer cement to seal it.
10. The pulpotomy-treated tooth will be prepared to receive a full-coverage stainless steel crown (SSC) after the procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulpitis - Reversible Occlusal Caries Proximal Caries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

occlusal decay

Primary molars diagnosed with reversible pulpits caused by occlusal decay

Group Type EXPERIMENTAL

Pulpotomy

Intervention Type PROCEDURE

* Local anesthesia will be administered, and the tooth will be isolated with a rubber dam.
* To minimize further bacterial contamination, carious tissues will be removed progressively, starting from the cavity periphery and then over the pulp chamber roof.
* Before managing the pulpal hemorrhage, a sterile cotton pellet will be placed over the pulp tissue for 30-45 s.
* A fresh sterile bur will be used to remove all coronal pulp tissue down to the root canal orifices, with copious water irrigation
* MTA will be used as medicament of choice for pulpotomy.
* The pulpotomy-treated tooth will be prepared to receive a full-coverage stainless steel crown (SSC) after the procedure.

Measuring Cytokines level

Intervention Type OTHER

measuring cytokines level as an indicator for pulp inflammation

Proximal decay

Primary molars diagnosed with reversible pulpits caused by Proximal decay.

Group Type ACTIVE_COMPARATOR

Pulpotomy

Intervention Type PROCEDURE

* Local anesthesia will be administered, and the tooth will be isolated with a rubber dam.
* To minimize further bacterial contamination, carious tissues will be removed progressively, starting from the cavity periphery and then over the pulp chamber roof.
* Before managing the pulpal hemorrhage, a sterile cotton pellet will be placed over the pulp tissue for 30-45 s.
* A fresh sterile bur will be used to remove all coronal pulp tissue down to the root canal orifices, with copious water irrigation
* MTA will be used as medicament of choice for pulpotomy.
* The pulpotomy-treated tooth will be prepared to receive a full-coverage stainless steel crown (SSC) after the procedure.

Measuring Cytokines level

Intervention Type OTHER

measuring cytokines level as an indicator for pulp inflammation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pulpotomy

* Local anesthesia will be administered, and the tooth will be isolated with a rubber dam.
* To minimize further bacterial contamination, carious tissues will be removed progressively, starting from the cavity periphery and then over the pulp chamber roof.
* Before managing the pulpal hemorrhage, a sterile cotton pellet will be placed over the pulp tissue for 30-45 s.
* A fresh sterile bur will be used to remove all coronal pulp tissue down to the root canal orifices, with copious water irrigation
* MTA will be used as medicament of choice for pulpotomy.
* The pulpotomy-treated tooth will be prepared to receive a full-coverage stainless steel crown (SSC) after the procedure.

Intervention Type PROCEDURE

Measuring Cytokines level

measuring cytokines level as an indicator for pulp inflammation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children with provoked pain.
* Caries in proximal surface to the dentine full thickness.
* Caries in occlusal surface to the dentine full thickness.
* Radicular pulp health is verified by achieving hemostasis within eight minutes of compression using a cotton pellet with 5% sodium hypochlorite.

Exclusion Criteria

* Unrestorable primary molars.
* Primary molars with spontaneous pain.
* Medically compromised patients who have systemic disease.
* Uncooperative children who refuse treatment.
* Children whose parents are unwilling to place stainless steel crowns.
* Children whose parents or caregivers refuse to participate in the study or are unable to attend follow-up visits.
Minimum Eligible Age

4 Years

Maximum Eligible Age

9 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yasmin Khalifa

PHD candidate

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hany Saber

Role: STUDY_CHAIR

Professor of Pediatric Dentistry, Faculty of dentistry, Cairo Univeristy

Maii Mohammed

Role: STUDY_DIRECTOR

lecturer of Pediatric Dentistry, Faculty of dentistry, Cairo Univeristy

Yasmin Magdi Khalifa

Role: PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cairo Univeristy

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yasmin Ma Khalifa, PhD Candidate

Role: CONTACT

+201000300634

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yasmin Magdi Khalifa

Role: primary

+201000300634

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

14422023529314

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.